NCT06211309

Brief Summary

Gingivitis is an inflammatory condition of the gingival tissue, most commonly caused by bacterial infection.The plaque control is considered the most important preventive factor concerning caries, gingivitis, and periodontitis Mechanical means of plaque control, e.g. tooth brushing, flossing and use of other mechanical devices are the most commonly used methods. However, ideal plaque control solely by mechanical means requires a significant effort and is difficult to achieve.This has led to the introduction of chemical methods of plaque control using antimicrobial agentsMore specifically, chemotherapeutic agents with antimicrobial properties, such as 0.12% chlorhexidine (CHX).chx has side effects encourage the need to develop alternative mouthwashes with similar efficacy but without these issues.hence the mouthwash enriched with a combination of aqueous extracts of Salvadora persica L. and green tea used as a substitution to CHX with minimal side effects .The objective of this study was to investigate the efficacy of the combination of Gt aqueous extract and Sp aqueous extract in reducing plaque buildup and gingivitis for 4 weeks duration.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
45

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started Jan 2024

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2024

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

January 8, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

January 18, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2024

Completed
Last Updated

January 30, 2024

Status Verified

January 1, 2024

Enrollment Period

4 months

First QC Date

January 8, 2024

Last Update Submit

January 28, 2024

Conditions

Keywords

Dental plaqueSalvadoraGreen teaMouthwashClinical trial

Outcome Measures

Primary Outcomes (1)

  • change in plaque index

    Mean amount plaque between different comparators. Mean amount plaque between different comparators as anti-plaque agent after rinsing with different comparators using means of modified quigely hein plaque index\[ Turesky ,1970

    0-30 days

Secondary Outcomes (3)

  • Change in BOP score

    0-30 Days

  • change in Gingival index

    0-30 days

  • Mean relative change in cytokine interleukin-6 level in salivary Fluid

    0-30 days

Study Arms (3)

co.mouthwash

ACTIVE COMPARATOR

15ml twice a day, rinse for 30sec refrain from eating or drinking for 30min

Drug: co.mouthwas

Kin mouthwash

PLACEBO COMPARATOR

15ml twice a day, rinse for 30sec refrain from eating or drinking for 30min

Other: Kin

Distilled water

PLACEBO COMPARATOR

15ml twice a day, rinse for 30sec refrain from eating or drinking for 30min

Other: Distilled water

Interventions

15ml twice a day, rinse for 30sec refrain from eating or drinking for 30min

Also known as: co
co.mouthwash
KinOTHER

15ml twice a day, rinse for 30sec refrain from eating or drinking for 30min

Kin mouthwash

15ml twice a day, rinse for 30sec refrain from eating or drinking for 30min

Distilled water

Eligibility Criteria

Age15 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Subjects aged more than 15 years-old who will volunteer to participate.
  • Participants who were apparently systemically healthy.
  • Not taking antibiotic and anti-inflammatory drugs in the last three months
  • Patients having generalized gingivitis with intact periodontium in which they have more than 30% bleeding sites with no PPD \>3 mm with no clinical attachment loss according to criteria proposed by

You may not qualify if:

  • Those with history of systemic chronic disease, immunocompromised patients.
  • Those currently using any mouthwash.
  • Those on antibiotic therapy, anti-inflammatory medications or NSAID during the study and at the last 3 months before the study.
  • Those having a history of hypersensitivity to any product used in the present study.
  • Those having periodontitis.
  • Those who smoker or alcoholism.
  • handicapped patient or patients with limited manual dexterities.
  • pregnant , lactating women or taking contraceptive pills.
  • Subjects wearing orthodontic appliances or removable dentures.
  • patients unwilling to participate in study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aliaa

Baghdad, 10011, Iraq

RECRUITING

MeSH Terms

Conditions

GingivitisDental Plaque

Condition Hierarchy (Ancestors)

InfectionsGingival DiseasesPeriodontal DiseasesMouth DiseasesStomatognathic DiseasesDental DepositsTooth Diseases

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

January 8, 2024

First Posted

January 18, 2024

Study Start

January 1, 2024

Primary Completion

May 1, 2024

Study Completion

July 1, 2024

Last Updated

January 30, 2024

Record last verified: 2024-01

Locations